MOLECULAR DESIGN OF POTENT INHIBITOR SPECIFIC FOR CATHEPSIN-B BASED ON THE TERTIARY STRUCTURE PREDICTION

被引:35
|
作者
SUMIYA, S
YONEDA, T
KITAMURA, K
MURATA, M
YOKOO, C
TAMAI, M
YAMAMOTO, A
INOUE, M
ISHIDA, T
机构
[1] TAISHO PHARMACEUT CO LTD, RES CTR, 1-403 YOSHINO CHO, OMIYA, SAITAMA 330, JAPAN
[2] OSAKA UNIV PHARMACEUT SCI, DEPT PHYS CHEM, MATSUBARA, OSAKA 580, JAPAN
关键词
CA-074; MOLECULAR DESIGN; CATHEPSIN-B; TERTIARY STRUCTURE PREDICTION; PAPAIN-E-64-C COMPLEX; RESTRAINED MOLECULAR DYNAMICS SIMULATION;
D O I
10.1248/cpb.40.299
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
To design a potent inhibitor specific for cathepsin B (rat liver), the tertiary structure was predicted based on the crystal structure of the papain complexed with (+)-(2S,3S)-3-{1-[N-(3-methylbutyl)amino]leucylcarbonyl}oxirane-2-carbolylic acid (E-64-c), a thiol protease inhibitor. Taking advantage of the structural characteristics of the predicted active site, seventeen inhibitors were chemically synthesized by molecular modeling, and one of them, N-(L-3-trans-propylcarbamoyloxirane-2-carbonyl)-L-isoleucyl-L-proline (CA-074) was shown to be the first potent inhibitor specific for cathepsin B. The relationship between the structure and inhibitory activity is discussed based on the model structure of the cathepsin B-inhibitor complex.
引用
收藏
页码:299 / 303
页数:5
相关论文
共 50 条
  • [1] CRYSTAL-STRUCTURES OF RECOMBINANT RAT CATHEPSIN-B AND A CATHEPSIN B-INHIBITOR COMPLEX - IMPLICATIONS FOR STRUCTURE-BASED INHIBITOR DESIGN
    JIA, ZC
    HASNAIN, S
    HIRAMA, T
    LEE, X
    MORT, JS
    TO, R
    HUBER, CP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (10) : 5527 - 5533
  • [2] POTENT NEW INHIBITORS OF CATHEPSIN-B
    SMITH, RA
    COLES, P
    COPP, LJ
    PAULS, HW
    ROBINSON, VJ
    SPENCER, RW
    KRANTZ, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1988, 195 : 81 - MEDI
  • [3] POTENT NEW INHIBITORS OF CATHEPSIN-B
    SMITH, RA
    COLES, P
    COPP, LJ
    PAULS, HW
    ROBINSON, VJ
    SPENCER, RW
    KRANTZ, A
    BIOCHEMISTRY, 1988, 27 (08) : 3080 - 3080
  • [4] Development of Cathepsin Inhibitors and Structure-Based Design of Cathepsin B-Specific Inhibitor
    Tomoo, Koji
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (07) : 696 - 707
  • [5] GENE STRUCTURE OF MOUSE CATHEPSIN-B
    FERRARA, M
    WOJCIK, F
    RHAISSI, H
    MORDIER, S
    ROUX, MP
    BECHET, D
    FEBS LETTERS, 1990, 273 (1-2) : 195 - 199
  • [6] SPECIFIC INHIBITORS AGAINST CARDIAC CATHEPSIN-B
    TOYOOKA, T
    ROSS, J
    CIRCULATION, 1980, 62 (04) : 243 - 243
  • [7] CARBOHYDRATE INHIBITOR OF CATHEPSIN-B ACTIVITY ASSOCIATED WITH HAPTOGLOBIN
    SNELLMAN, O
    SYLVEN, B
    EXPERIENTIA, 1974, 30 (10): : 1114 - 1115
  • [8] SYNTHESIS AND ACTIVITY OF A NOVEL, IRREVERSIBLE INHIBITOR OF CATHEPSIN-B
    CULLEN, BM
    MCGINTY, A
    WALKER, B
    NELSON, J
    HALLIDAY, I
    BAILIE, JR
    KAY, G
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1990, 18 (02) : 315 - 316
  • [9] IDENTIFICATION OF NEOPLASM-SPECIFIC CATHEPSIN-B PROENZYMES
    KEPPLER, D
    PAGANO, M
    DALETFUMERON, V
    FONDANECHE, MC
    BURTIN, P
    ENGLER, R
    BULLETIN DU CANCER, 1987, 74 (06) : 716 - 716
  • [10] CONFORMATIONAL STUDIES OF CATHEPSIN-B - INTERACTION WITH SPECIFIC ANTIBODIES
    BANSAL, R
    SINGH, S
    KIDWAI, JR
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 1981, 18 (02): : 110 - 113